European guidelines on upper tract urothelial carcinomas: 2013 update.
about
Systemic Inflammatory Response Based on Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker in Bladder CancerPrognostic Genetic Signatures in Upper Tract Urothelial CarcinomaUpper urinary tract disease: what we know today and unmet needsUpper tract urothelial carcinoma: Paradigm shift towards nephron sparing managementLynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact?Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancerRisk stratification for kidney sparing procedure in upper tract urothelial carcinomaThe association between the TERT rs2736100 AC genotype and reduced risk of upper tract urothelial carcinomas in a Han Chinese populationStandards of the Polish Ultrasound Society - update. Ultrasound examination of the kidneys, ureters and urinary bladder.A Pilot Study of In Vivo Confocal Laser Endomicroscopy of Upper Tract Urothelial Carcinoma.Nephroureterectomy surgery in the UK in 2012: British Association of Urological Surgeons (BAUS) Registry data.Survival Comparison Between Endoscopic and Surgical Management for Patients With Upper Tract Urothelial Cancer: A Matched Propensity Score Analysis Using Surveillance, Epidemiology and End Results-Medicare Data.Prognostic significance of urothelial carcinoma with divergent differentiation in upper urinary tract after radical nephroureterectomy without metastatic diseases: A retrospective cohort study.Hypoxia-regulated MicroRNA-210 Overexpression is Associated with Tumor Development and Progression in Upper Tract Urothelial Carcinoma.Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study.Impact of gender on tumor stage and survival of upper urinary tract urothelial cancer : A population-based study.Upper tract urothelial carcinomas in patients with chronic kidney disease: relationship with diagnostic challenge.Ureter regeneration-the proper scaffold has to be defined.Impact of squamous and glandular differentiation on oncologic outcomes in upper and lower tract urothelial carcinoma.Diffusion-weighted MRI as a potential imaging biomarker reflecting the metastatic potential of upper urinary tract cancer.Robot-assisted versus laparoscopic nephroureterectomy for upper-tract urothelial cancer: A population-based assessment of costs and perioperative outcomes.The risk of kidney cancer in patients with kidney stones: a systematic review and meta-analysis.Recent advances in ureteral tissue engineering.The impact of method of distal ureter management during radical nephroureterectomy on tumour recurrenceSquamous cell carcinoma in a duplicated renal pelvis.Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy.Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tract.TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCRThe characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision.[Elective organ and function preservation in ureter and renal pelvis tumors].Miniature forward-viewing common-path OCT probe for imaging the renal pelvisHigh expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.The effect of intravesical chemotherapy in the prevention of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomyCDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladderPreoperative C-reactive protein as a prognostic predictor for upper tract urothelial carcinoma: A systematic review and meta-analysis.Concurrent Preoperative Presence of Hydronephrosis and Flank Pain Independently Predicts Worse Outcome of Upper Tract Urothelial Carcinoma.Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial CarcinomaEarly repeated ureteroscopy within 6-8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings.The role of diagnostic ureteroscopy in the era of computed tomography urography.
P2860
Q26765951-8BB1F515-EEF2-4BD0-9E3F-BCE48658F8DDQ26772220-5A32CBF7-748A-41CF-B0AD-ACBB2A38E652Q26773671-B55947B3-C6A5-4259-A51B-610BABC5CF19Q28066806-B556B6BC-78A3-4774-A31F-27070758C4E5Q28067471-9EF8A71C-E460-4C7D-BD9B-1CDDA157C01AQ28076041-4C2713F3-0224-4DA2-8127-C279128477BDQ28077825-48916D1F-4B5A-4424-9ECB-DD02A6D94F27Q28392404-42C29425-59EE-483F-B4D9-1F2821019B70Q30396120-7D6A99F6-DD2A-4FB0-BB02-689066A713E9Q30688672-7A8CD668-7EEC-4387-922A-430A509EB595Q30829545-136DB214-5E1F-4F58-BCA6-45CDFDD6E65DQ31103185-A7748C1D-A41C-46C9-81BD-258220FE1D02Q33760541-6148687D-069A-458F-9275-4AC05BE9BB55Q33820638-613DAB15-82FA-43F5-BA6D-45EA383C6301Q33840690-AFFA9987-F6FA-43C2-BB97-2CB708D08981Q33841250-AD349B73-FE33-4E19-9B76-5762256656A4Q34080219-BEADC3D0-9404-48F0-A0D8-1F57D58C5150Q34097580-38A264A7-8953-4445-AEA1-899A7C0D546CQ34142394-C06A86BE-358E-4E65-9AF3-6EF757ECC301Q34223163-D13E0C0A-B973-4320-94D4-9C6B2DCDBC82Q34436049-5DB450AD-29A7-4369-8AFB-644E5BA36BA9Q34437835-A4587511-D36E-4271-B5D8-063812E13AF8Q34528395-3A6A0459-C5C7-4F17-8146-2377D4889ABAQ34602179-DEF82819-23ED-4B10-9C6D-B092D7516FA1Q34732812-437F3560-EF05-4337-BD3D-315C08C79DD0Q34962464-AD508DA0-8C99-43BE-BDEE-2C51761FDCE1Q35016935-1A8C9BE7-CA6D-4C06-B00D-63B7229625BFQ35068013-63171282-3A58-4C6D-B21C-3081CA3DD275Q35086043-262D7A69-FCFB-46DE-92D9-77FAED0B1B5DQ35230042-6B8767C5-9268-4F5E-8DEB-F1C013A2ADF8Q35445526-66CA343F-7719-4456-A505-8DF618FC0F41Q35609624-C8288998-69A2-4CE7-95D2-D3DE5F9EBD59Q35629317-36C07537-03D8-4697-AE45-906E2765A44EQ35644091-6EA748CB-18F6-4AC0-AA33-791A92EE1C71Q35682594-45795B73-75DF-46A2-AD27-7C424E47BCEEQ35690319-9263241B-8E14-4C65-82F7-5530CB8696CEQ35808709-D4C62803-3699-4FBF-A693-A63A96AAF689Q35837779-B0D54DE0-CEE0-48B3-BBEE-04E780361C4BQ35877277-F5A96419-BE09-449B-B278-8514DE1B95ADQ35888994-8700EC91-6E81-483F-9813-E2721E59F15D
P2860
European guidelines on upper tract urothelial carcinomas: 2013 update.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
European guidelines on upper tract urothelial carcinomas: 2013 update.
@en
type
label
European guidelines on upper tract urothelial carcinomas: 2013 update.
@en
prefLabel
European guidelines on upper tract urothelial carcinomas: 2013 update.
@en
P2093
P1433
P1476
European guidelines on upper tract urothelial carcinomas: 2013 update.
@en
P2093
Andreas Böhle
Bas W G Van Rhijn
Eero Kaasinen
European Association of Urology
Eva Compérat
Joan Palou
Marko Babjuk
Max Burger
Morgan Rouprêt
Nigel Cowan
P304
P356
10.1016/J.EURURO.2013.03.032
P407
P577
2013-03-19T00:00:00Z